Innovations
Pharco Corporation collaborates with most reputable national and international science facilities, R&D companies in addition to Pharco R&D centers, to discover and develop effective medications to treat the most challenging diseases, with the constant advancement in medical care.
The need for new medicine continues to grow and that’s why our pipeline for new medicines in development stages includes a project on hepatitis C anti-viral medication and a project on oral Insulin.
Our efforts have blossomed in the development of three new break-through products available in the Egyptian market, which are ;
Pedyphar (ointment for the treatment of diabetic foot), Mirazid, (soft gelatin capsules for the treatment of Bilharziasis, Fascioliasis and other parasites) and Aloreed (ointment for the treatment of Psoriasis), collaborating for more than 15 years with national scientists, national and international scientific and medical research centers.
We are constantly developing our generic products to have fewer side effects, higher bioavailability, higher efficacy, and a faster onset action.
Our researchers continue to work around the clock to turn ideas into cures that eventually give hope to patients in need.